名稱(chēng) | EML4(E13)-ALK(E20) Translocation |
型號(hào) | CBP20209D |
報(bào)價(jià) | ![]() |
特點(diǎn) | EML4(E13)-ALK(E20) Translocation |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- 細(xì)胞株培養(yǎng)傳代時(shí)的指數(shù)增生期解讀
- 【產(chǎn)品推介】RANKL抗體篩選模型
- IL-22藥篩細(xì)胞模型
- LTβR信號(hào)通路誘導(dǎo)三級(jí)淋巴結(jié)構(gòu)的形成,促進(jìn)趨化因子的表達(dá)
- CCR8 | 潛在重磅腫瘤免疫治療靶點(diǎn)
- 三陰性乳腺癌的一個(gè)突破口——BRCA基因檢測(cè)?
- 腸道守護(hù)者--GLP2R
- 【分享】NIST開(kāi)發(fā)ERBB2- CNV標(biāo)準(zhǔn)品的一些思路
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Translocation > CBP20209DEML4(E13)-ALK(E20) Translocation

- 詳細(xì)內(nèi)容
EML4(E13)-ALK(E20) Translocation EML4(E13)-ALK(E20) Translocation
Introduction | |
Format | DNA |
Description | EML4-ALK results from the fusion of EML4 and ALK, resulting in constitutive kinase activity, transformation in cultured cells, and tumor formation in mouse models . EML4-ALK fusions have been associated with non-small cell lung cancer . |
Technical Data | |
Left Gene | EML4(E13) |
Left Breakpoint | chr2:425****6:+ |
Right Gene | ALK(E20) |
Right Breakpoint | chr2:294****4:- |
%AF | 50% |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purity | Download for COA |
RNA electrophoresis | Download for COA |
Sanger sequencing | Download for COA |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">